CS
ELAN icon

Candriam SCA’s Elanco Animal Health ELAN Stock Holding History

Candriam SCA’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,041
Closed -$208K – 768
2023
Q1 		$208K Buy
+24,041
New +$284K ﹤0.01% 870
2022
Q4 		– Sell
-17,975
Closed -$223K – 870
2022
Q3 		$223K Sell
17,975
-4,835
-21% -$84.5K ﹤0.01% 861
2022
Q2 		$448K Sell
22,810
-4,145
-15% -$98.1K ﹤0.01% 735
2022
Q1 		$703K Buy
26,955
+4,464
+20% +$119K ﹤0.01% 711
2021
Q4 		$638K Hold
22,491
– – ﹤0.01% 729
2021
Q3 		$717K Hold
22,491
– – ﹤0.01% 748
2021
Q2 		$780K Buy
22,491
+651
+3% +$21.5K 0.01% 755
2021
Q1 		$643K Hold
21,840
– – 0.01% 693
2020
Q4 		$670K Hold
21,840
– – 0.01% 704
2020
Q3 		$610K Sell
21,840
-5,069
-19% -$128K 0.01% 693
2020
Q2 		$577K Sell
26,909
-5,581
-17% -$123K 0.01% 693
2020
Q1 		$935K Hold
32,490
– – 0.01% 663
2019
Q4 		$957K Sell
32,490
-4,190
-11% -$114K 0.01% 680
2019
Q3 		$975K Buy
36,680
+11,900
+48% +$357K 0.01% 616
2019
Q2 		$834K Buy
+24,780
New +$805K 0.01% 684

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Candriam SCA's ELAN Position: Q2 2023 in Review

Candriam SCA sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 24,041 shares — an estimated $208K sold.

Candriam SCA first reported a position in ELAN in Q2 2019 and held it in 15 quarters. The position peaked at $975K in Q3 2019. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Candriam SCA reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 24,041 Elanco Animal Health shares in Q2 2023, an estimated $208K.
  • Candriam SCA first reported a position in Elanco Animal Health in Q2 2019 and held it in 15 quarters.
  • Candriam SCA's Elanco Animal Health position peaked at $975K in Q3 2019.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.